Synthesis and activity of dimeric bradykinin antagonists containing diaminodicarboxylic acid bridge residues

Journal of Peptide Science

Volumn 4, Issue 4, 1998, Pages 289-293

  Lange, Meinolf ^a   Cuthbertson, Alan S ^a   Towart, Robertson ^b   Fischer, Peter M ^a,c  

^a ALTANA PHARMA AG   (Germany)

^b Nycomed Holdings AS   (Austria)

^c CYCLACEL LTD   (United Kingdom)

Author keywords

Bradykinin antagonist; Bridge residue; Diaminodicarboxylic acid; Dimer

Indexed keywords

BRADYKININ RECEPTOR; CROSS LINKING REAGENT; DIAMINE; DICARBOXYLIC ACID;

ANIMAL; ARTICLE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; GUINEA PIG; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MUSCLE CONTRACTION;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-LINKING REAGENTS; DIAMINES; DICARBOXYLIC ACIDS; GUINEA PIGS; MUSCLE CONTRACTION; RECEPTORS, BRADYKININ;

EID: 0032084729     PISSN: 10752617     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1387(199806)4:4<289::AID-PSC146>3.0.CO;2-T     Document Type: Article

References (23)

1. R.J. Vavrek and J.M. Stewart (1985). Competitive antagonists of bradykinin. Peptides 6, 161-164.
2. N.E. Rhaleb, G. Drapeau, S. Dion, D. Jukic, N. Rouissi and D. Regoli (1990). Structure-activity studies on bradykinin and related peptides: agonists. Br. J. Pharmacol. 99, 445-448.
3. J.M. Stewart and R.J. Vavrek in: Peptides: Chemistry and Biology Proceedings at the 10th American Peptide Symposium, G.R. Marshall, Ed., p. 433-437, ESCOM, Leiden 1988.
4. 2 receptor characterization. TiPS 11, 156-161.
5. F.J. Hock, K. Wirth, U. Albus, W. Linz, H.J. Gerhards, G. Wiemer, S. Henke, G. Breipohl, W. Koenig, J. Knolle and B.A. Schoelkens (1991). Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies. Br. J. Pharmacol. 102, 769-773.
6. 2 antagonist activity. J. Med Chem. 37, 348-355.
7. R.A. Roth, D.J. Cassell, D.O. Morgan, M.A. Tatnell, R.H. Jones, A. Schüttler and D. Brandenburg (1984). Effects of covalently linked insulin dimers of receptor kinase activity and receptor down regulation. FEBS Lett. 170, 360-364.
8. Y. Higuchi, Y. Takano, H. Shimazaki, Y. Shimohigashi, H. Kodama, H. Matsumoto, K. Sakaguchi, S. Nonaka, R. Saito, M. Waki and H.-O Kamiya (1989). Dimeric substance P analogue shows a highly potent activity in the in vivo salivary secretion in the rat. Eur. J. Pharmacol. 160, 413-416.
9. J. Stepinski, I. Zajaczkowski, D. Kazem-Bek, A. Temeriusz, A.W. Lipkowski and S.W. Tam (1991). Use of hydrophilic diamines for bridging of two opioid peptide pharmacophores. Synthesis and receptor binding of two new analogues. Int. J. Peptide Protein Res. 38, 588-592.
10. 3-6, in complex with 5′-TGACT-3′ sites by two-dimensional NMR. J. Am. Chem. Soc. 115, 9900-9906.
11. M.B. Stolz and J.-L. Fauchère (1988). Synthesis and steroidogenic activity of covalently dimerized corticotropin (ACTH) fragments. Helv. Chim. Acta 71, 1421-1428.
12. H. Matsumoto, Y. Shimohigashi, Y. Takano, S. Sakaguchi, H.-O. Kamiya and M. Ohno (1993). Optimum cross-linking spacer length of dimeric neurokinin B analogs for interaction with NK-1 tachykinin receptors. Bull. Chem. Soc. Jpn 66, 196-204.
13. I. Ojima, Q. Dong, M. Eguchi, Y.-I. Oh, C.M. Amann and B.S. Coller (1994). Structure-activity relationship of double-stranded RGD peptides as gpIIb/IIIa receptor antagonists. Bioorg. Med. Chem. Lett. 4, 1749-1754.
14. J.C. Cheronis, E.T. Whalley, K.T. Nguyen, S.R. Eubanks, L.G. Allen, M.J. Duggan, S.D. Loy, K.A. Bonham and J.K. Blodgett (1992). A new class of bradykinin antagonists: Synthesis and in vitro activity of bissuccinimidoalkane peptide dimers. J. Med. Chem. 35, 1563-1572.
15. R.F. Nutt, R.G. Strachan, D.F. Veber and F.W. Holly (1980). Useful intermediates for synthesis of dicarba analogues of cystine peptides: Selectively protected α-aminosuberic and α, α′-diaminosuberic acid of defined sterochemistry. J. Org. Chem. 45, 3078-3080.
16. P.K. Bhatnager, E.K. Agner, D. Alberts, B.E. Arbo, J.F. Callahan, A.S. Cuthbertson, S.J. Engelsen, H. Fjerdingstad, M. Hartmann, D. Heerding, J. Hiebl, W.F. Huffman, M. Husben, A.G. King, P. Kremminger, C. Kwon, S. LoCastro, D. Løvhaug, L. Pelus, S. Petteway and J.S. Takata (1996). Structure-activity relationship of novel hemoregulatory peptides. J. Med. Chem. 39, 3814-3819.
17. P.M. Fischer, M. Solbakken and K. Undheim (1994). Solution synthesis of a dimeric pentapeptide: Diketopiperazine cyclisation of Glu-Asp dipeptide esters and Asp-racemisation during segment condensation. Tetrahedron 50, 2277-2288.
18. G. Bold, T. Allmendinger, P. Herold, L. Moesch, H.P. Schär and R.O. Duthaler (1992). Stereoselektive Synthese von (2S,6S)-2,6-Diaminoheptandisäure und von usymmetrischen Derivaten der meso-2,6-Diaminoheptandisäure. Helv. Chim. Acta 75, 865-882.
19. E. Atherton and R.C. Sheppard: Solid Phase Peptide Synthesis: A Practical Approach, p. 87-89, IRL Press, Oxford 1989.
20. G.B. Fields and R.L. Noble (1990). Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int. J. Peptide Protein Res. 33, 161-214.
21. L. Gera, J.M. Stewart, E. Whalley, M. Burkard and J.S. Zuzack (1996). A new class of potent bradykinin antagonist dimers. Immunopharmacology 33, 178-182.
22. D. Chan, L. Gera, B. Helfrich, K. Helm, J. Stewart, E. Whalley and P. Bunn (1996). Novel bradykinin antagonist dimers for the treatment of human lung cancers. Immunopharmacology 33, 201-204.
23. J.M. Stewart and R.J. Vavrek (1987). Bradykinin competitive antagonists: design and activities. Adv. Biosci. 65, 73-80.